alvocidib

cyclin dependent kinase 1 ; Homo sapiens







33 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34067359 DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A. 2021 May 22 2
2 34233076 Design, synthesis, and primary activity assays of baicalein derivatives as cyclin-dependent kinase 1 inhibitors. 2021 Oct 1
3 30250647 Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. 2018 Aug 31 2
4 28176922 Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel. 2017 1
5 27771926 Potential Use of Flavopiridol in Treatment of Chronic Diseases. 2016 1
6 23943501 The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells. 2013 Nov 2
7 20419498 Homology modeling, molecular dynamic simulation and docking studies of cyclin dependent kinase 1. 2011 Feb 4
8 21885916 VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. 2011 Nov 1 1
9 20206141 Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. 2010 Jul 1 2
10 21042745 Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells. 2010 Dec 1
11 17638911 Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. 2007 Jul 15 1
12 14751090 Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents. 2004 Mar 1
13 15023361 Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication. 2004 Mar 11 1
14 15217973 Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol. 2004 Jun 15 2
15 15308730 Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors. 2004 Sep 2
16 15474478 Molecular models of cyclin-dependent kinase 1 complexed with inhibitors. 2004 Nov 12 6
17 12813134 Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. 2003 Jun 1
18 14519054 Clinical pharmacology of flavopiridol following a 72-hour continuous infusion. 2003 Oct 1
19 14562039 Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process. 2003 Oct 16 1
20 11960485 Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics. 2002 Apr 25 2
21 12054639 Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol. 2002 Apr 26 4
22 11464216 The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway. 2001 Jul 2
23 11063609 Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. 2000 Nov 2 3
24 11093360 Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. 2000 Dec 1
25 10363974 Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. 1999 Jun 1 2
26 10500810 Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. 1999 1
27 10665481 Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. 1999 1
28 16127615 Small molecule anticancer drugs. 1999 Jun 2
29 9427698 Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. 1998 Jan 15 2
30 9802881 Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. 1998 Nov 1 2
31 8674031 Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. 1996 Jul 1 1
32 8895733 Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. 1996 Nov 1 2
33 21541623 Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. 1996 Dec 1